Dehaier Acquired Multiple International Players' Authorization for Chinese Government Procurement
Dehaier Medical Systems Ltd. (Nasdaq: DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and sleep respiratory products in China, today announced that it will serve as the exclusive product-appointed distribution agent for some of the world's leading medical equipment companies in bidding for multiple government procurement projects in China, the procurement projects we are bidding for are designated by these companies.
The appointed products the company is authorized for the procurement include Harmonic System from Johnson & Johnson Medical (Shanghai) Ltd., the MasterScreen™ pulmonary function testing system from CareFusion (Shanghai) Commercial and Trading Co. Ltd., ventilator from Weinmann GmbH + Co. KG, infusion pump from B. Braun Medical (Shanghai) International Trading Co., Ltd., spectrophotometer from Shimadzu (China) Co., Ltd. and portable color Doppler ultrasound, versatile anesthesia machine and multi-parameter monitor from Mindray Medical International Limited. The aggregate value of the procurement projects is expected to be approximately $21 million.
Dehaier Chairman and CEO Mr. Ping Chen stated, "With rich experience and resources in the Chinese medical equipment industry, especially with its mature sales and distribution networks across China, Dehaier has earned a strong reputation and increased product support from global medical equipment companies who seek to penetrate the vast Chinese healthcare market. Today we are excited and honored to enter into these exclusive arrangements with international medical equipment manufacturers to distribute their flagship products in China and to participate in potential government procurement projects. In the past year, the Chinese government procurement business has been one of Dehaier's major focuses. With a fast growing economy and aging population, we believe the Chinese government will continue to invest more to upgrade its healthcare system, particularly China's medical equipment. By partnering with world-renowned medical device companies, we are confident that our government procurement business will progress in 2014 and beyond. Dehaier is currently working on a preparation for the procurement biddings and expects to win them in quarters to come."
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.